EE Impact

Allergan

Ireland · Pharma & Healthcare

LeaveRussia detail: Exit Completed

Exited Russia

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.

Status last verified 03/08/2026Source checked 30/09/2025Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 23/07/2025 · Reference ↗

Another company suspended its work in Russia - the Irish concern Allergan. 23.07.2025: The legal entity Allergan CIS SARL LLC was liquidated.

Local stats (LeaveRussia)

Assets(RF), mln.USD
17
Capital(RF), mln.USD
15
Glob.Revenue, mln.USD
16090
Revenue(RF), mln.USD
0
Staff(RF), 2021
178
Taxes(RF), mln.USD
5

Status history since 2022

  1. 03/08/2026 exited · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.